The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
in Europe and #21 in the world for aerospace engineering
students
companies founded by graduates and faculty in the last 10 years
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSAs seen on nocamels.com.
People suffering from narrowed or semi-blocked arteries in their legs can find themselves in a vicious cycle – not doing any exercise because of the pain it entails, but finding that the lack of activity only exacerbates the condition.
A newly developed implant that sits just under the skin on the leg is intended to dilate and enhance blood flow through those narrowed arteries with ultrasonic waves, allowing crucial oxygen-rich blood to reach the lower limbs and ease the pain.
Peripheral Artery Disease (PAD) is a condition that restricts the flow of oxygenated blood from the heart to the legs, causing pain when exercising as the muscles do not receive sufficient oxygen for the motion – a disorder known as claudication.
MEDX Xelerator is a medical-device-focused incubator and investor operating under the Israel Innovation Authority. MEDX Xelerator CEO Shai Policker and CTO Gal Atarot are both Technion alumni.
by
nocamels.com (opens in a new tab)
on
December 27, 2023
Explore how innovative technology is improving blood flow through narrowed arteries, easing pain for those with Peripheral Artery Disease.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Heart Health / Alumni / Biotech / Healthy Aging /
Why do so many life-saving technologies never make it out of the lab? Prof. Marcelle Machluf demonstrates how combining scientific rigor with business vision is the only way to bring practical solutions to the patients who need them most. As a case in point, she shares her personal transformation from researcher to entrepreneur. This talk […]
Can the future of nutrition be more personalized, even down to our biology? A new study from the Technion suggests it can. Researchers in the Faculty of Biotechnology and Food Engineering recently discovered that men and women digest milk and plant-based milk alternatives differently — a breakthrough that could have far-reaching implications for nutrition science, […]
This op-ed is authored by Jenny Goldstein, chief development officer of the American Technion Society. For anyone who has faced a cancer diagnosis, or watched someone they love go through one, there is a particular anguish that comes with uncertainty. For me, that feeling is deeply personal. My father, an engineer whose love of science […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.